Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes is a paper indexed in PICO Portal from OpenAlex.
How many citations does Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes have?
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes has 336 citations in the OpenAlex counts PICO Portal stores.
When was Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes published?
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes has 2025 year in the PICO Portal index.
What is the open-access status of Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes?
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes has green oa status in the PICO Portal index.
What is the DOI of Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes?
The DOI for Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes is on the source record.
What is the PMID of Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes?
The PMID for Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes is on the source record.
What is the OpenAlex record for Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes?
The OpenAlex for Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes is on the source record.